What Is the Right Way for a Private Company to Raise Capital from a Chinese Investor?
Chinese Investment in a U.S. Company
We often hear from U.S. companies with a business contact in China who wants to invest. The proposed deal may sound simple: agree on a valuation, sign the documents, and wire the money. It rarely works that way. A U.S. company accepting investment from China must address U.S. securities laws, CFIUS, and China’s restrictions on moving money overseas. Any one of those can delay or derail the investment.
What Should the U.S. Company Do?
The company should investigate the investor and the proposed source of funds before negotiating final terms. It should then structure the offering under an available securities-law exemption, determine whether CFIUS has jurisdiction, and confirm that the investor can lawfully move the investment funds out of China.
1. Comply with U.S. Securities Laws
Selling stock, convertible debt, a SAFE, or another investment interest generally involves the offer and sale of a security. Unless the offering is registered with the Securities and Exchange Commission, the company must qualify for an exemption from registration.
Regulation S provides a safe harbor for qualifying offers and sales made outside the United States, but it does not apply merely because the investor is Chinese. The transaction must satisfy Regulation S’s offshore-transaction requirements, and the company must avoid directed selling efforts in the United States. If the financing also includes U.S. investors, the company often relies on a separate exemption, such as Regulation D. State securities laws, investor disclosures, resale restrictions, and required filings still need attention. Paying an unregistered intermediary a percentage of the money raised can create an additional broker-dealer problem, as discussed in our article on finder’s fees in U.S. capital raises.
2. Analyze CFIUS Before Granting Rights
The Committee on Foreign Investment in the United States (CFIUS) reviews certain foreign investments in U.S. businesses for national-security risks. CFIUS can review transactions that give a foreign investor control over a U.S. business. It can also review some non-controlling investments in businesses involving critical technology, critical infrastructure, or sensitive personal data. Board seats, observer rights, access to technical information, and influence over important business decisions can matter as much as the investor’s ownership percentage.
Some transactions require a filing. Others permit the parties to submit a declaration or full notice voluntarily. A cleared transaction generally receives safe-harbor protection, while an unfiled transaction can be reviewed after closing. CFIUS can impose mitigation conditions and, in serious cases, force the parties to unwind the investment. Chinese investments receive particularly close scrutiny. The company should conduct its CFIUS analysis before promising governance, information, or access rights—not after the term sheet has been signed. For a fuller explanation, see U.S. Foreign Investment and the New CFIUS Rules and CFIUS Reporting Requirements for Non-U.S. Investors.
3. Confirm That the Money Can Leave China
China’s US$50,000 annual personal foreign-exchange quota is often misunderstood. It is not a US$50,000 allowance for overseas investments. A Chinese resident generally cannot use the personal quota to buy shares in a U.S. company. The lawful route depends on who is investing, where the money is held, and how the transaction is structured. A mainland Chinese company making an overseas investment generally must complete the applicable Chinese outbound-investment and foreign-exchange procedures. An individual investor faces a different and often more difficult set of restrictions.
A U.S. company should require credible evidence that the investor can lawfully transfer the full investment amount. It should not accept vague assurances that the investor will pool relatives’ quotas, route the money through unrelated parties, misdescribe the payment, or “find a way.” Those are warning signs, not financing plans.
4. Document the Investment Properly
Once the regulatory path is clear, the parties still need ordinary investment documents covering valuation, voting rights, information rights, board participation, transfer restrictions, dilution, exit rights, and representations about the investor and the source of funds. The documents should also address what happens if Chinese approval, U.S. regulatory clearance, or funding does not arrive by the closing date. A signed investment agreement is worth little if the investor cannot lawfully deliver the money.
The Bottom Line
A Chinese investor can invest in a private U.S. company, but the company should not treat the transaction as a routine domestic financing. Before signing final documents, confirm three things: the securities offering qualifies for an exemption, the proposed investment rights do not create an unresolved CFIUS problem, and the investor has a lawful route for moving the money out of China. If any of those remains uncertain, the company does not yet have a financeable deal.
